T cell receptor Dδ2Dδ3 rearrangement: A suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia

Leukemia

Volumn 11, Issue 5, 1997, Pages 759-761

  Seriu, T ^a   Erz, D ^a   Stark, Y ^a   Bartram, C R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute lymphoblastic leukemia; D 2D 3 rearrangement; Minimal residual disease; TCR gene

Indexed keywords

SIGNAL PEPTIDE; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; CANCER GENETICS; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MARKER GENE; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; T LYMPHOCYTE RECEPTOR GENE;

EID: 0030967508     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400643     Document Type: Article

References (14)

1. van Dongen JJM, Wolvers-Tettero ILM. Analysis of immuno-globulin and T-cell receptor genes. Part I: basic and technical aspects. Clin Chim Acta 1991; 198: 1-91.
2. van Dongen JJM, Wolvers-Tettero ILM. Analysis of immuno-globulin and T-cell receptor genes. Part II: possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta 1991 ; 198:93-174.
3. Bartram CR. Detection of minimal residual leukemia by the polymerase chain reaction: potential implications for therapy. Clin Chim Acta 1993; 217: 75-83.
4. Campana D, Pui C-H. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Stood 1995; 85: 1416-1434.
5. Blondi A, di Celle PF, Rossi V, Casorati G, Matullo G, Giudici G, Foa R, Migone N. High prevalence of T-cell receptor Vδ2-(D)-Dδ3 or Dδ1/2-Dδ3 rearrangements in B-precursor acute lymphoblastic leukemias. Blood 1990; 75: 1834-1840.
6. van Dongen JJM, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6 (Suppl. 1) 47-59.
7. Breit TM, Wolvers-Tettero ILM, Beishuizen A, Verhoven MAJ, van Wering ER, van Dongen JJM. Southern blot patterns, frequencies and junctional diversity of T-cell receptor-5 gene rearrangements in acute lymphoblastic leukemia. Blood 1993; 82: 3063-3074.
8. van Dongen JJM, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. Immunophenotypic and immunogenotypic detection of minimal residual disease in acute lymphoblastic leukemia. Recent Res Cancer Res 1993; 131: 157-184.
9. Bartram CR, Seriu T, Hansen-Hagge TE, Janssen JWG, Ludwig W-D. Molecular biological detection of minimal residual disease in acute lymphoblastic leukemia. In: Büchner T, Hiddemann W, Wörmann B, Schellong G, Ritter J, Creutzig U (eds). Acute Leukemia VI - Prognostic Factors and Treatment Strategies. Springer-Verlag: Berlin, Heidelberg, 1997, pp 313-320.
10. Ludwig W-D, Bartram CR, Ritter J, Raghavachar A, Hiddemann W, Heil G, Harbott J, Seibt-Jung H, Teichmann JV, Riehm H. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988; 71: 1518-1528.
11. van der Does-van der Berg A, Bartram CR, Basso G, Benoit YCM, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Köller U, Lampert F, Ludwig W-D, Niemeyer CM, van Wering ER. Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BFM Family' cooperative group. Med Pediatr Oncol 1992; 20: 497-505.
12. Yokota S, Hansen-Hagge TE, Ludwig W-D, Reiter A, Raghavachar A, Kleihauer E, Bartram CR. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77: 331-339.
13. Breit TM, Wolvers-Tettero ILM, Hählen K, van Wering ER, van Dongen JJM. Extensive junctional diversity of γδ T-cell receptors expressed by T-cell acute lymphoblastic leukemia: implications for the detection of minimal residual disease. Leukemia 1991; 5: 1076-1086.
14. Seriu T, Hansen-Hagge TE, Erz DHR, Bartram CR. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions. Leukemia 1995; 9: 316-320.